2 Night Stay
Check In
Day -1
Check Out
Day 2
You are reading:
Healthy Participants
|
High Blood Pressure Study
Healthy Participants
High Blood Pressure Study
Start date
Various Dates Available
Renumeration
$8,565
2 night stay, 19 appointments
Trial for participants with mild to moderate hypertension
This research study investigates a new treatment for high blood pressure, also known as hypertension (HTN). HTN is the leading risk factor for cardiovascular disease and premature mortality globally, with its prevalence increasing, particularly in low- to middle-income countries.
The study focuses on evaluating a novel gene therapy that targets a specific gene responsible for producing a protein involved in the regulation of blood pressure. By reducing levels of this protein, the study aims to normalise blood pressure in participants with mild to moderate HTN.
Schedule
Example Cohort
19
appointment
Day 8, Day 15, Day 22, Day 29, Day 43, Day 57, Day 71, Day 85, Day 99, Day 127, Day 155, Day 183, Day 211, Day 239, Day 267, Day 295, Day 323, Day 351, Day 365
To Qualify, You Must
Age
Be 18 to 65 years old
Gender
Be a healthy male or female
Physical Condition
Healthy with mild to moderate hypertension.
NOT have any allergies to food or medications.
Have NO significant medical conditions.
NOT be a heavy smoker.
Requirements
Mild to moderate hypertension with mean sitting systolic blood pressure of >130 and ≤160 mmHg.
Have a BMI between 18 and 35kg/m2.
Renumeration
$8,565 * with Screening Reimbursement please see Terms
Trial for participants with mild to moderate hypertension
Spots are limited. Find out if you qualify today!
